Trials / Completed
CompletedNCT00002201
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
Safety and Efficacy of Ritonavir (ABT-538) in Combination With Nelfinavir in HIV-Infected Subjects.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if it is safe and effective to give ritonavir plus nelfinavir to HIV-infected patients. This study will also see how ritonavir and nelfinavir are absorbed by the body and how they affect the level of HIV in the blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ritonavir | |
| DRUG | Nelfinavir mesylate |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2009-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00002201. Inclusion in this directory is not an endorsement.